Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aquinox Pharmaceuticals Inc (NASDAQ:AQXP)

16.96
Delayed Data
As of Feb 24
 +0.12 / +0.71%
Today’s Change
6.01
Today|||52-Week Range
19.97
+2.73%
Year-to-Date
No recent news for Aquinox Pharmaceuticals Inc.

Today’s Trading

Previous close16.84
Today’s open16.73
Day’s range16.51 - 17.05
Volume44,862
Average volume (3 months)157,494
Market cap$397.3M
Dividend yield--
Data as of 3:59pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+37.09%
Earnings growth (this year)-4.05%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.69

Competitors

 Today’s
change
Today’s
% change
TLGTTeligent Inc+0.14+1.93%
MACKMerrimack Pharmaceut...-0.05-1.63%
CARACara Therapeutics In...+0.48+3.30%
COLLCollegium Pharmaceut...+0.13+0.93%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$0.00
Annual profit (last year)-$21.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
David J. Main
Chief Financial Officer, Secretary &
VP
Kamran Alam
Corporate headquarters
Vancouver, British Columbia

Forecasts


Search for Jobs